Natixis Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Sell
1,622,749
-1,122,079
-41% -$90.5M 0.14% 141
2026
Q1
$238M Buy
2,744,828
+49,077
+2% +$4.7M 0.33% 68
2025
Q4
$259M Buy
2,695,751
+77,975
+3% +$7.57M 0.37% 48
2025
Q3
$249M Buy
2,617,776
+240,545
+10% +$22.1M 0.36% 43
2025
Q2
$207M Buy
2,377,231
+511,494
+27% +$43.4M 0.33% 56
2025
Q1
$168M Buy
1,865,737
+442,609
+31% +$39.6M 0.31% 67
2024
Q4
$114M Buy
1,423,128
+78,918
+6% +$6.83M 0.21% 99
2024
Q3
$121M Buy
1,344,210
+158,299
+13% +$13.3M 0.24% 96
2024
Q2
$93.3M Buy
1,185,911
+107,329
+10% +$8.8M 0.2% 107
2024
Q1
$94M Buy
1,078,582
+15,245
+1% +$1.3M 0.22% 106
2023
Q4
$87.6M Buy
1,063,337
+83,816
+9% +$6.39M 0.23% 103
2023
Q3
$76.8M Buy
979,521
+55,433
+6% +$4.64M 0.23% 98
2023
Q2
$81.4M Buy
924,088
+92,178
+11% +$7.94M 0.25% 96
2023
Q1
$67.1M Buy
831,910
+347,282
+72% +$28.3M 0.23% 114
2022
Q4
$37.7M Sell
484,628
-258,947
-35% -$21M 0.14% 177
2022
Q3
$60M Buy
743,575
+255,695
+52% +$23M 0.25% 101
2022
Q2
$43.8M Sell
487,880
-192,957
-28% -$19.6M 0.19% 132
2022
Q1
$75.5M Sell
680,837
-62,443
-8% -$6.6M 0.29% 83
2021
Q4
$76.9M Sell
743,280
-124,493
-14% -$14.4M 0.29% 75
2021
Q3
$109M Buy
867,773
+96,083
+12% +$12.4M 0.45% 46
2021
Q2
$95.8M Sell
771,690
-69,987
-8% -$8.79M 0.45% 42
2021
Q1
$99.4M Buy
841,677
+30,587
+4% +$3.58M 0.52% 34
2020
Q4
$95M Sell
811,090
-22,267
-3% -$2.45M 0.55% 35
2020
Q3
$86.6M Buy
833,357
+45,327
+6% +$4.55M 0.54% 33
2020
Q2
$72.3M Buy
788,030
+17,931
+2% +$1.72M 0.48% 36
2020
Q1
$69.4M Sell
770,099
-88,938
-10% -$9.46M 0.57% 33
2019
Q4
$97.5M Buy
859,037
+60,247
+8% +$6.61M 0.69% 22
2019
Q3
$86.8M Buy
798,790
+68,739
+9% +$7.17M 0.69% 23
2019
Q2
$71.1M Buy
730,051
+45,798
+7% +$4.18M 0.58% 32
2019
Q1
$62.3M Buy
684,253
+54,394
+9% +$4.87M 0.55% 36
2018
Q4
$57.3M Buy
629,859
+4,905
+0.8% +$458K 0.57% 37
2018
Q3
$61.5M Buy
624,954
+5,516
+0.9% +$510K 0.54% 37
2018
Q2
$53M Sell
619,438
-123,771
-17% -$10.3M 0.51% 37
2018
Q1
$59.6M Buy
743,209
+34,443
+5% +$2.84M 0.59% 30
2017
Q4
$57.2M Buy
708,766
+156,175
+28% +$12.5M 0.58% 30
2017
Q3
$43M Sell
552,591
-57,194
-9% -$4.75M 0.45% 41
2017
Q2
$54.1M Buy
609,785
+11,573
+2% +$976K 0.59% 34
2017
Q1
$48.2M Buy
598,212
+142,042
+31% +$11.1M 0.53% 35
2016
Q4
$32.5M Buy
456,170
+91,154
+25% +$7.16M 0.39% 50
2016
Q3
$31.5M Sell
365,016
-29,760
-8% -$2.59M 0.41% 49
2016
Q2
$34.3M Buy
394,776
+33,696
+9% +$2.72M 0.47% 40
2016
Q1
$27.1M Buy
361,080
+34,500
+11% +$2.6M 0.41% 44
2015
Q4
$25.1M Buy
326,580
+92,976
+40% +$7M 0.41% 43
2015
Q3
$15.6M Sell
233,604
-64,219
-22% -$4.73M 0.27% 68
2015
Q2
$22.1M Buy
297,823
+36,600
+14% +$2.8M 0.37% 40
2015
Q1
$20.4M Buy
261,223
+131,002
+101% +$9.93M 0.36% 44
2014
Q4
$9.4M Buy
130,221
+9,980
+8% +$693K 0.18% 142
2014
Q3
$7.45M Buy
120,241
+2,652
+2% +$169K 0.15% 187
2014
Q2
$7.5M Buy
117,589
+14,389
+14% +$874K 0.11% 311
2014
Q1
$6.35M Buy
103,200
+2,393
+2% +$139K 0.1% 345
2013
Q4
$5.79M Buy
100,807
+2,433
+2% +$138K 0.09% 358
2013
Q3
$5.24M Sell
98,374
-15,162
-13% -$816K 0.1% 362
2013
Q2
$5.84M Buy
+113,536
New +$5.61M 0.12% 293

Other funds holding MDT

Natixis Advisors's MDT Position: Q2 2026 in Review

Natixis Advisors reduced its Medtronic (MDT) stake by 41% in Q2 2026, selling an estimated $90.5M and leaving 1,622,749 shares worth $127M. The position accounts for 0.14% of the portfolio, ranked #141.

Natixis Advisors first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $259M in Q4 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Natixis Advisors held 1,622,749 shares of Medtronic worth $127M as of Q2 2026.
  • Natixis Advisors sold 1,122,079 Medtronic shares in Q2 2026, an estimated $90.5M.
  • Medtronic made up 0.14% of Natixis Advisors's portfolio in Q2 2026, its #141 holding.
  • Natixis Advisors first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Natixis Advisors's Medtronic position peaked at $259M in Q4 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.